Skip to content

Author

S.-B. Wang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

[CD19-targeted in vivo CAR-T cell therapy for high-risk/refractory B-acute lymphoblastic leukemia: a case report and literature review].

The case preliminarily supports the feasibility and potential clinical value of in vivo CAR-T cell therapy in high-risk, heavily pretreated B-ALL patients and provides a valuable practical reference for clinical application.

Y. Li, F.-Y. Ma, L.-H. Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.